A detailed history of Choate Investment Advisors transactions in Abbott Laboratories stock. As of the latest transaction made, Choate Investment Advisors holds 175,537 shares of ABT stock, worth $18.2 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
175,537
Previous 158,820 10.53%
Holding current value
$18.2 Million
Previous $17.5 Million 14.13%
% of portfolio
0.54%
Previous 0.54%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$109.52 - $120.96 $1.83 Million - $2.02 Million
16,717 Added 10.53%
175,537 $20 Million
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $2.96 Million - $3.63 Million
32,855 Added 26.08%
158,820 $17.5 Million
Q3 2023

Oct 30, 2023

BUY
$95.53 - $114.62 $424,535 - $509,371
4,444 Added 3.66%
125,965 $12.2 Million
Q2 2023

Aug 01, 2023

BUY
$100.78 - $112.29 $786,184 - $875,974
7,801 Added 6.86%
121,521 $13.2 Million
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $465,702 - $548,160
4,808 Added 4.41%
113,720 $11.5 Million
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $127,855 - $149,994
1,345 Added 1.25%
108,912 $12 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $296,279 - $343,035
3,062 Added 2.93%
107,567 $10.4 Million
Q2 2022

Aug 11, 2022

BUY
$102.07 - $123.37 $584,452 - $706,416
5,726 Added 5.8%
104,505 $11.4 Million
Q1 2022

Apr 29, 2022

BUY
$114.02 - $139.04 $47,318 - $57,701
415 Added 0.42%
98,779 $11.7 Million
Q4 2021

Feb 07, 2022

BUY
$115.53 - $141.46 $526,123 - $644,208
4,554 Added 4.85%
98,364 $13.8 Million
Q3 2021

Nov 04, 2021

SELL
$116.66 - $129.06 $67,079 - $74,209
-575 Reduced 0.61%
93,810 $11.1 Million
Q2 2021

Jul 30, 2021

BUY
$105.79 - $124.53 $291,028 - $342,582
2,751 Added 3.0%
94,385 $10.9 Million
Q1 2021

May 07, 2021

BUY
$108.84 - $128.23 $58,229 - $68,603
535 Added 0.59%
91,634 $11 Million
Q4 2020

Feb 08, 2021

SELL
$105.0 - $114.42 $46,725 - $50,916
-445 Reduced 0.49%
91,099 $9.97 Million
Q3 2020

Oct 26, 2020

SELL
$91.64 - $111.29 $52,784 - $64,103
-576 Reduced 0.63%
91,544 $9.96 Million
Q2 2020

Jul 23, 2020

SELL
$76.57 - $98.0 $162,328 - $207,760
-2,120 Reduced 2.25%
92,120 $8.42 Million
Q1 2020

May 07, 2020

SELL
$62.82 - $91.86 $138,518 - $202,551
-2,205 Reduced 2.29%
94,240 $7.44 Million
Q4 2019

Jan 28, 2020

SELL
$78.51 - $87.4 $2,276 - $2,534
-29 Reduced 0.03%
96,445 $8.38 Million
Q3 2019

Nov 13, 2019

SELL
$81.84 - $88.74 $104,591 - $113,409
-1,278 Reduced 1.31%
96,474 $8.07 Million
Q2 2019

Aug 14, 2019

SELL
$72.88 - $85.0 $129,945 - $151,555
-1,783 Reduced 1.79%
97,752 $8.22 Million
Q1 2019

Apr 29, 2019

BUY
$66.22 - $80.06 $95,621 - $115,606
1,444 Added 1.47%
99,535 $7.96 Million
Q4 2018

Feb 14, 2019

SELL
$65.56 - $74.27 $95,586 - $108,285
-1,458 Reduced 1.46%
98,091 $7.1 Million
Q3 2018

Nov 14, 2018

SELL
$60.81 - $73.36 $442,453 - $533,767
-7,276 Reduced 6.81%
99,549 $7.3 Million
Q2 2018

Jul 30, 2018

SELL
$57.57 - $63.54 $328,609 - $362,686
-5,708 Reduced 5.07%
106,825 $6.52 Million
Q1 2018

May 04, 2018

SELL
$56.27 - $63.62 $181,358 - $205,047
-3,223 Reduced 2.78%
112,533 $0
Q4 2017

Feb 14, 2018

SELL
$53.68 - $57.47 $278,008 - $297,637
-5,179 Reduced 4.28%
115,756 $0
Q3 2017

Nov 14, 2017

BUY
$48.06 - $53.64 $5.81 Million - $6.49 Million
120,935
120,935 $0

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $182B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Choate Investment Advisors Portfolio

Follow Choate Investment Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Choate Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Choate Investment Advisors with notifications on news.